Fate Therapeutics Stock Performance
as on October 3, 2026 at 2:15 pm IST
Day's Low
Day's High
$2.27$2.36
2.16%
Downside
1.72%
Upside
52 Week's Low
52 Week's High
$0.95$3.2359.05%
Downside
39.22%
Upside
Fate Therapeutics share price movements today
- Previous Close
- $2.30
- Open
- $2.33
- Volume
- 708.0K
- Market Cap
- $275.6M
- Day's Low - High
- $2.27 - $2.36
- 52 Week Low - High
- $0.95 - $3.23
Fate Therapeutics Historical Returns
- 1 Month Return
- -4.13 %
- 3 Month Return
- -20.55 %
- 1 Year Return
- + 91.74 %
- 3 Year Return
- + 26.09 %
- 5 Year Return
- -96.1 %
Fate Therapeutics Stock Fundamentals & Key Indicators
Check Fate Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$275.6M
EPS (TTM)
-1.05
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.23
Industry PE ratio
-6.16
PEG Ratio
-0.07
EBITDA
-117.2M
Revenue (TTM)
6.5M
Profit Margin
-343.01%
Return On Equity TTM
-65.08%
Fate Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Fate Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $275.6M | -96.10% | -2.23 | -343.01% | 0.00% | |
| StrongBuy | $44.1B | 609.62% | -23.34 | 0.00% | 0.00% | |
| Neutral | $75.4B | -44.29% | -24.08 | -12.57% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $78.1B | 28.80% | 17.67 | 84.86% | 0.50% |
Stock Returns calculator for Fate Therapeutics Stock including INR - Dollar returns
The Fate Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Fate Therapeutics investment value today
Current value as on today
₹2,08,082
Returns
₹1,08,082
(+108.08%)
Returns from Fate Therapeutics Stock
₹91,736 (+91.74%)
Dollar Impact
₹16,346 (+16.35%)
Analyst Recommendation on Fate Therapeutics Stock
Based on 4 analysts
50.00%
Buy
50.00%
Hold
0.00%
Sell
Based on 4 analysts, 50% of analysts recommend a 'BUY' rating for Fate Therapeutics. Average target price of $5.74
Fate Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Fate Therapeutics.
What analysts predicted
59.58%UPSIDE
Target Price
$5.74
Current Price
$2.32
Analyzed by
4 Analysts
High
$8
Target
$5.74
Low
$7
Fate Therapeutics target price $5.74, a slight upside of 59.58% compared to current price of $2.32. According to 4 analysts rating.
Indian Investors' Interest in Fate Therapeutics Stock
Search interest for Fate Therapeutics Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Fate Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Fate Therapeutics Annual Profit & Loss
All numbers in Millions USD
Fate Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Fate Therapeutics Annual Cash Flow
All numbers in Millions USD
Fate Therapeutics News & Key Events
Today's Timeline - 02 September
Wed, 10:00 PM
-Fate Therapeutics launches Phase 2 trial for FT819 in lupus nephritis, aiming for significant kidney response.
Wed, 10:01 PM
-Fate Therapeutics announces FT839 trial for autoimmune diseases, expanding its pipeline beyond oncology.
Insights on Fate Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -32.37M → -30.15M (in $), with an average increase of 3.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, FATE stock has moved up by 90.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.29M → 2.08M (in $), with an average increase of 37.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 475.2%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 50.4%
About Fate Therapeutics
| Organisation | Fate Therapeutics |
| Headquarters | 12278 Scripps Summit Drive, San Diego, CA, 92131, US |
| Industry | Biotechnology |
| CEO | Bahram Valamehr |
Key Management of Fate Therapeutics
Name | Title |
|---|---|
Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
Ms. Jessica Francis | Senior Vice President of Human Resources & Operations |
Dr. Martin Hosking | Head of Research |
Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations & Quality |
Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
Mr. Kamal Adawi M.S., MBA | CFO & Treasurer |
Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Mr. Ryan Douglas | Senior Director of Investor Relations & Business Development |
Mr. Andrew Henry | Senior Vice President of Clinical Operations |
Ms. Kate Duvall | Corporate Controller |
FAQs
What is Fate Therapeutics share price today?
Fate Therapeutics share price today is $2.32 as on at the close of the market. Fate Therapeutics share today touched a day high of $2.36 and a low of $2.27.
What is the 52 week high and 52 week low for Fate Therapeutics share?
Fate Therapeutics share touched a 52 week high of $3.23 on and a 52 week low of $0.95 on . Fate Therapeutics stock price today i.e. is closed at $2.32,which is 28.17% down from its 52 week high and 144.21% up from its 52 week low.
What is Fate Therapeutics's market capitalisation today?
Fate Therapeutics market capitalisation is $0.00T as on .
How to invest in Fate Therapeutics Stock (FATE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Fate Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Fate Therapeutics Stock (FATE) from India?
Indian investors can start investing in Fate Therapeutics (FATE) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Fate Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Fate Therapeutics share’s latest price of $2.32 as on October 3, 2026 at 8:45 am IST, you will get 4.3103 shares of Fate Therapeutics. Learn more about
fractional shares .
What are the returns that Fate Therapeutics has given to Indian investors in the last 5 years?
Fate Therapeutics stock has given -96.1% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?